For instance, genetically predicted lower LV expression of TMEM182 (encoding a regulator of myoblast differentiation34) and lower genetically predicted blood expression of FBXO32 (a recessive DCM gene35,36) were associated with increased DCM risk. This evidence concerns the gene TMEM182 and familial dilated cardiomyopathy.